Roos Van Elzen

A prolyl oligopeptidase inhibitor, KYP‐2047, reduces α‐synuclein protein levels and aggregates in cellular and animal models of Parkinson's disease

MJ Hannula, Roos Van Elzen, Melanie Gérard et al. · British Journal of Pharmacology · 2012 · 101 citations

Metal ions shape α-synuclein

Rani Moons, Albert Konijnenberg, Carl Mensch et al. · Scientific Reports · 2020 · 89 citations · Full text

The proteome of the human neuroblastoma cell line SH-SY5Y: An enlarged proteome

Kambiz Gilany, Roos Van Elzen, Kim Mous et al. · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · 2008 · 42 citations

Neuro-oncology, Tumor Innervation, Ependyma +10

Raman optical activity of human <i>α</i>‐synuclein in intrinsically disordered, micelle‐bound <i>α</i>‐helical, molten globule and oligomeric <i>β</i>‐sheet state

Carl Mensch, Albert Konijnenberg, Roos Van Elzen et al. · Journal of Raman Spectroscopy · 2017 · 40 citations · Full text

Dynamics and ligand-induced conformational changes in human prolyl oligopeptidase analyzed by hydrogen/deuterium exchange mass spectrometry

Alexandra Tsirigotaki, Roos Van Elzen, Pieter Van der Veken et al. · Scientific Reports · 2017 · 33 citations · Full text